Sandoz creates biosimilar unit to benefit from major patent cliff
Source: SeekingAlpha
2026-03-10 11:59:24 ET
More on Sandoz Group AG
- Sandoz Group AG 2025 Q4 - Results - Earnings Call Presentation
- Sandoz Group AG (SDZNY) Q4 2025 Earnings Call Transcript
- Sandoz: The Share Price May Have Run Its Course
- Sandoz Group AG Non-GAAP EPS of $3.64 beats by $0.38, revenue of $11.1B beats by $20M
- Sandoz wins FDA nod to expand Enzeevu label to multiple retinal indications
Read the full article on Seeking Alpha
For further details see:
Sandoz creates biosimilar unit to benefit from major patent cliff
Sandoz Group Ag Shs
NASDAQ: SDZXF
SDZXF Trading
0.0% G/L:
$79.90 Last:
1,533 Volume:
$79.90 Open:
